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Abstract
A manufacturer utilizes methylene chloride (CH2Cl2) (CAS 75-09-2), also known as
dichloromethane, to manufacture active pharmaceutical ingredients. Methylene chloride is
specifically regulated by the Occupational Safety and Health Administration (OSHA) under 29
Code of Federal Regulation (CFR) 1910.1052. Evaluation and documentation of employee
exposure to methylene chloride is required to comply with OSHA regulations. In addition to
OSHA compliance, it is also important to evaluate employee exposure levels to determine if
respiratory protection, regulation of the work area, and medical monitoring are necessary.
This industrial hygiene report describes an investigation into the risks of exposure to methylene
chloride. This report includes evaluation of employee exposure to methylene chloride during the
manufacture of active pharmaceutical ingredients. During the manufacture of active
pharmaceutical ingredients, employees transfer methylene chloride from small containers to a
large reactor. After the desired reaction has taken place and allowed to separate, different layers
of the solution which contains methylene chloride are drained from the reactor into small
containers. Employees have the potential for exposure to methylene chloride during the transfer
and collection processes.
The results of the occupational exposure sampling indicate employees are exposed to levels of
methylene chloride above the permissible exposure limit (PEL) and the action limit (AL). The
regulatory standard requires medical monitoring when employees are exposure above the AL.
Regulation of the work area and respiratory protection is required at the PEL.
Recommendations to reduce exposure include identifying a substitute solvent that is less
hazardous. To control exposure through an engineering control, an evaluation of the current
localized ventilation system would be valuable in determining existing capabilities for reducing
exposure to methylene chloride vapors. If this is not possible with the current ventilation system,
other ventilation options could be explored. An engineering control to reduce exposure during
methylene chloride transfer from pails to the reactor may be achieved by applying nitrogen
pressure to the bucket to force methylene chloride from one container to the reactor vessel from a
remote location. Reduction of exposure during transfer from the bottom of the reactor to
collection pails may be achieved by attaching a hose to the bottom of the reactor and channeling
discharge into a closed top container. The implementation of either of these controls would
necessitate additional exposure monitoring to evaluate the effectiveness.

Keywords:
Methylene chloride, dichloromethane, exposure monitoring, active pharmaceutical ingredient
manufacturing
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Glossary of Terms

Term
29 CFR 1910.1052

Definition
29 Code of Federal Regulation (CFR) 1910.1052 is known as the
methylene chloride standard

AIHA

American Industrial Hygiene Association

AL

Action Level is established by OSHA as the 8-hour time-weighted
average exposure level at which exposure regulatory requirements
are applicable

ATSDR

Agency for Toxic Substances and Disease Registry

PEL

Permissible Exposure Limit established by OSHA to protect workers
from adverse exposure effects based on an 8-hour time-weighted
average

NIOSH

National Institute of Occupational Safety and Health

OSHA

Occupational Safety and Health Administration

TWA

Time-weighted average; the average exposure over a given period of
time
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1. Introduction
A manufacturer utilizes methylene chloride (CH2Cl2) (CAS 75-09-2), also known as
dichloromethane, to manufacture active pharmaceutical ingredients. Methylene chloride is
specifically regulated by the Occupational Safety and Health Administration (OSHA) under 29
Code of Federal Regulation (CFR) 1910.1052. To comply with this regulation, it is necessary to
conduct an initial exposure determination to determine employees’ exposure levels. The
manufacturer indicated exposure monitoring had been conducted and exposure limits were below
the action level (AL) and permissible exposure limit (PEL). However, documentation pertaining
to the exposure monitoring, including the calculated exposure levels, was unavailable.
Evaluation and documentation of employee exposures to methylene chloride is required
to comply with the OSHA methylene chloride standard. It is also important to evaluate employee
exposure levels to determine if respiratory protection, regulation of the work area, and medical
monitoring are necessary.
This industrial hygiene report will include a review of the risks of exposure to methylene
chloride. This project will also include evaluation of employee exposure to methylene chloride
during the manufacture of active pharmaceutical ingredients. The results of the exposure
evaluation provided in this report were used to recommend appropriate actions (e.g., regulatory
compliance, engineering controls, additional monitoring).

1.1. Process Description
The process of manufacturing active pharmaceutical ingredients is a multi-step process.
Chemicals used in the manufacturing process are transferred from the suppliers’ containers (e.g.,
drums, 4-liter bottles, pails) to properly labeled 5-gallon pails which are then weighed and staged
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in the work area (see Figure 1). These transfer activities are performed the day prior to initiating
manufacturing activities and were not included in this evaluation.
Figure 1: Pails containing chemicals staged in the work area.

As the manufacturing process begins, the first step includes charging the reactor (i.e.,
pouring materials into the reactor) with a proprietary compound, methylene chloride and
additional chemicals to facilitate a reaction. To accomplish this step, Employee 1 climbs steps to
an elevated platform that is staged near the reactor (see Figure 2). Employee 2 carries the pails to
the elevated platform. Employee 1 then opens the containers and pours the contents into the
reactor. At this time, localized ventilation (i.e., a snorkel, trunk exhaust duct or extraction arm) is
positioned near the opening of the reactor (see Figure 3). The localized ventilation is provided by
a Plymovent extraction arm which is intended to capture chemical vapors. The employees wear
supplied-air, full-faced respirators, laboratory coats and chemical-compatible gloves. This
portion of the manufacturing process occurs intermittently over an approximate four hour period
as dictated by the desired reaction and quenching of the reaction.

3
Figure 2: View of the elevated platform with reactor in the background

Figure 3: Movable ventilation duct.

After allowing time for the phases of the solution to separate, the aqueous layer of the
material is then released from the reactor through a drain at the bottom of the reactor into
appropriately labeled 5-gallon pails (see Figure 4). After additional stirring, the material is
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allowed time to separate again. The methylene chloride layer (i.e., the halogenated waste layer)
is then collected in to appropriately labeled 5-gallon pails. At this time, localized ventilation (i.e.,
extraction arm) is positioned near the discharge location at the bottom of the reactor. The
employees wear supplied-air, full-faced respirators, laboratory coats and chemical-compatible
gloves. This activity occurs intermittently over an approximate four hour period.
Figure 4: Bucket staged below reactor to capture separated layers.

The remaining material is then filtered as it is removed. The liquid potion is captured in
pails while the solids are captured on a filtering cloth. The employees wear supplied-air, fullfaced respirators, laboratory coats and chemical-compatible gloves. This typically occurs the
next day over an approximate 15 minute period.

2. Hypotheses
As the methylene chloride exposure level was not established, it was unknown if
respiratory protection, regulation of the work area, and medical monitoring are necessary to meet
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the requirements of 1910.1052. This evaluation is important to determine regulatory compliance
responsibilities.
Information about the toxicology of methylene chloride and background information as
to the risks of methylene chloride exposure are provided in Section 4 which emphasizes the
importance of evaluating methylene chloride exposure levels.
This research was designed and implemented with the intention of answering the
following question: “what is the methylene chloride exposure level for employees manufacturing
active pharmaceutical ingredients?” From this question, the following hypotheses were
developed:

Null 1: Employee exposure to methylene chloride will be equal to or less than the OSHA PEL.
R 1:

Employee exposure to methylene chloride will be greater than the OSHA PEL.

Null 2: Employee exposure to methylene chloride will be equal to or less than the OSHA AL.
R 2:

Employee exposure to methylene chloride will be greater than the OSHA AL.

To reject or not reject the null hypotheses, exposure monitoring was conducted to
determine the exposure level.
The final portion of the industrial hygiene report includes a discussion of the findings,
conclusions, and recommendations. If either null hypothesis 1 or null hypothesis 2 are rejected,
medical surveillance is required in accordance with 29 CFR 1910.1052. Further if null
hypothesis 1 is rejected, regulation of the work area and engineering controls, administrative
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controls, or personal protective equipment such as full-faced, supplied-air respirators are
required to reduce employee exposure below the PEL.

3. Background
Methylene chloride, a chlorinated hydrocarbon, is a colorless liquid with high vapor
pressure and a sweet odor (Agency for Toxic Substances and Disease Registry (ATSDR), 2000).
It is easily evaporated, but does not readily burn (ATSDR, 2000). Methylene chloride is not
naturally occurring; rather it is made from methane gas or wood alcohol (ATSDR, 2000). The
chemical and physical properties of methylene chloride are presented in Table I.
Table I: Chemical/Physical Data
Parameter
Molecular Weight
Boiling Point
Specific Gravity (water = 1)
Vapor Density (air = 1)
Vapor Pressure at 20°C (68°F)
Solubility in Water (grams/100 grams water at
20°C (68°F))
Appearance and Odor
(NIOSH, 2011 and ECSA, 2007)

Methylene Chloride Properties
84.9
39.8°C (104°F)
1.3
2.9
350 millimeters mercury (mm Hg)
1.32
Colorless liquid, chloroform-like odor

3.1. Toxicology
The primary route of exposure to methylene chloride, a volatile organic compound, is
through inhalation. As methylene chlorine is inhaled, over seventy percent is absorbed by the
bloodstream and reaches a steady state in the blood within one to two hours of continuous
exposure (Klaasen, 2008 and ATSDR, 2000). In the bloodstream, methylene chloride is
distributed throughout the body with most of it going to the liver, kidney, brain, lungs and fatty
tissue (ATSDR, 2000). Of the absorbed dose, less than five percent is exhaled as unchanged
methylene chloride, while 25 to 34 percent is exhaled as carbon monoxide, an end metabolite of
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methylene chloride (Klaasen, 2008). A small amount of methylene chloride leaves the body in
urine (ATSDR, 2000). Methylene chloride is quickly eliminated from the body and was not
shown to accumulate over a five day exposure regimen (Klaasen, 2008).
A small amount of methylene chloride can be absorbed by the skin; however, when
trapped against the skin by clothing or gloves, skin absorption can be greater and result in
potential chemical burns (ATSDR, 2000).
Absorption of methylene chloride through dermal exposure is relatively slow in
comparison to inhalation. In scenarios where employees are wearing supplied-air, full face
respirators and the skin is not protected (i.e., the employees are not wearing gloves), a sufficient
amount of methylene chloride may be absorbed through the skin over an 8-hour work period to
result in an internal concentration which would exceed that of employees exposed to methylene
chloride by inhalation of 25 ppm for eight hours (OSHA, 2012). Employees at risk of hand
contact with methylene chloride must wear impermeable gloves to prevent this route of exposure
(OSHA, 2012).
Methylene chloride is believed to be metabolized via three pathways as illustrated in
Figure 5 (EPA, 2011).
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Figure 5: Proposed pathways for methylene chloride metabolism
(a.k.a. Methylene Chloride)

1

2

3

4

1 – Mixed function oxidase pathway
2 – Glutathione transferase pathway
3 – Nucleophile pathway

One of the pathways involves cytochrome P450 2E1 (CYP2E1)-catalyzed oxidation of
methylene chloride to carbon monoxide via the reactive intermediate formyl chloride and is
referred to as the mixed function oxidase (MFO) pathway (see Figure 5) (Klaasen, 2008 and
ATSDR, 2000). This pathway is a high-affinity, low-capacity pathway and is the main pathway
of methylene chloride metabolism for occupational exposure (Klaasen, 2008). It is suggested that
this is the preferred pathway for the metabolism of inhaled methylene chloride (ATSDR, 2000).
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As shown in Figure 5, the second pathway (i.e., the glutathione transferase pathway) is a
glutathione (GSH)-mediated pathway involving the theta-class glutathione transferase (GST),
GSTT1-1 (Klaasen, 2008 and ATSDR, 2000). The conjugation of GSH and methylene chloride
results in the formation of reactive intermediates (i.e., S-(chloromethyl)glutathione and
formaldehyde) which are eventually metabolized to carbon dioxide. The GST pathway is a lowaffinity, high-capacity pathway which is operative at high exposure levels (Klaasen, 2008).
The suggested third pathway includes the formation of carbon dioxide via the MFO
pathway due to the reaction of intermediate, proposed to be formyl chloride, with a nucleophile,
such as glutathione (GSH), prior to the elimination of the chlorine ion (Klaasen, 2008 and
ATSDR, 2000).

3.2. Exposure Standards
The OSHA regulation 29 CFR 1910.1052 establishes an AL of 12.5 ppm as an 8-hour
time-weighted average (TWA) and a PEL of 25 ppm as an 8-hour TWA (OSHA, 2012). OSHA
has also established a short-term exposure limit (STEL) of 125 ppm as measured over a fifteen
minute exposure period (OSHA, 2012).
In accordance with the regulatory standard, the employer must establish regulated areas
(i.e., restricted area that is demarcated) when the PEL or the STEL are expected to be exceeded.
In addition, when the PEL or STEL may be exceeded, the employer must provide respiratory
protection. Only full face, supplied-air respirators are acceptable for methylene chloride
exposure. Medical surveillance is required when employees are exposed at or above the AL for
30 or more days per year or exceedances of the PEL or STEL for ten or more days per year. In
addition, medical surveillance is also required if an employee is at risk from cardiac disease or
other methylene chloride-related health condition.
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When feasible, the employer must institute and maintain engineering controls and work
practices to reduce employee exposure to below the PEL and STEL. Respiratory protection is
then used to supplement engineering controls and work practices after the lowest level of
exposure is achieved.
The National Institute of Occupational Safety and Health (NIOSH) has not established a
recommended exposure limit (REL) as measured for up to a 10-hour exposure period during a
40-hour work week for methylene chloride (NIOSH, 2011). NIOSH identifies methylene
chloride as a potential carcinogen and, therefore, recommends a “no exposure detectable levels
for proven carcinogenic substances”. NIOSH intends to provide a REL based on human and/or
animal data (NIOSH, 2011). NIOSH has identified an immediately dangerous to life and health
(IDLH) level of 2,300 ppm (NIOSH, 2011). If the IDLH level is reached, the work area should
be immediately evacuated.
The American Conference of Governmental Industrial Hygienists (ACGIH) has
established a threshold limit value (TLV) for methylene chloride of 50 ppm as measured over an
8-hour period during a 40-hour work week.
The German Commission for the Investigation of Health Hazards of Chemical
Compounds in the Work Area (MAK Commission) has classified methylene chloride as a
Category 3A carcinogen (i.e., a suspected carcinogen for which additional data is needed for
further classification). (Greim, 2001). The MAK occupational exposure limit (OEL) is 100 ppm
as measured over an 8-hour TWA (ECSA, 2007).
The Netherland, the United Kingdom and Switzerland have established an 8-hour TWA
OEL for methylene chloride of 100 ppm (ECSA, 2007). Sweden and France have also
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established 8-hour TWA OELs for methylene chloride of 35 ppm and 50 ppm, respectively
(ECSA, 2007).

3.3. Site Evaluated
The process evaluated is detailed in section 1.1 Process Description. The work activities
are restricted to one room of the manufacturer’s facility. Employees return to their office while
waiting for the reaction to take place or the solution in the reactor to separate.

4. Effects of Exposure
4.1. Target Organs
Methylene chloride is considered a potential human carcinogen and is a confirmed
carcinogen in rodents (Klaasen, 2008 and OSHA, 1997). Studies to date show little evidence of
methylene chloride carcinogenicity in humans (Klaasen, 2008). OSHA concluded that a positive
association between human exposure to methylene chloride and cancer incidence exists, but that
the dose response relationship is not clear (OSHA, 1997) Additional research may clarify if
methylene chloride is a human carcinogen.
Other toxic effects of methylene chloride exposure include effects to the central nervous
system, cardiac toxicity, hepatic toxicity, and reproductive toxicity (OSHA, 1997).
Relatively mild, but reversible central nervous system depression is seen in humans when
inhaled at low levels including levels as low as 200 ppm (OSHA, 1997). Depression of the
central nervous system as a result of methylene chloride exposure is characterized by tiredness
and a decrease in attentiveness (OSHA, 1997). It has been suggested that repeated exposure to
high levels of methylene chloride could result in irreversible central nervous system depression,
however, a review of the studies by OSHA concluded that the results of these studies is not
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supported (OSHA, 1997). Monitoring of future research by OSHA will continue due to concern
about potential central nervous system effects at low levels (OSHA, 1997).
Cardiac health effects are anticipated due to exposure to methylene chloride, or more
specifically, the metabolite, carbon monoxide (OSHA, 1997). Carbon monoxide competes with
oxygen and binds to hemoglobin producing carboxyhemoglobin (COHb) (OSHA, 1997). The
reduction in oxygen delivery to tissues can result in myocardial infarction (OSHA, 1997).
Animal studies have shown no evidence of direct toxic effects on cardiac tissue as the result of
methylene chloride exposure (OSHA, 1997). In human studies, methylene chloride exposure
resulted in increased blood COHb (OSHA, 1997). Human baseline levels of COHb are typically
less than 1% (OSHA, 1997). Measurements of COHb of 24% and 30% were reported by one
human study, but were believed to only occur at high levels of exposure to methylene chloride
(i.e., greater than 500 ppm) (OSHA, 1997). OSHA, while concerned about the metabolism of
methylene chloride to carbon monoxide, has determined that the risk for cardiac health effects is
low (OSHA, 1997). OSHA will continue evaluate new research on this health effect (OSHA,
1997).
It is suspected that methylene chloride could be toxic to the liver as are other chlorinated
hydrocarbons (e.g., carbon tetrachloride and chloroform) (OSHA, 1997). Mild liver effects (i.e.,
mild inflammatory response) were noted in rats and mice exposed to methylene chloride (OSHA,
1997). In studies evaluating the chronic exposure of rats, mice and hamsters to methylene
chloride, increased fatty liver, cytoplasic vacuolization and increased number of multinucleated
hepatocytes were noted hepatic effects. OSHA’s review of these animal studies concluded that
rodent livers are sensitive to chronic effects, but not acute effects of methylene chloride exposure
(OSHA, 1997). Human studies provided mixed results. A study of acetate fiber production plant
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workers was suggestive of a hepatotoxic response (i.e., increases in serum bilirubin and alanine
aminotransferase) (OSHA, 1997). Hepatotoxic effects (i.e., liver function and enlarged liver)
were also suggested of floor tile setters which were chronically exposed to methylene chloride at
concentrations between 400 and 5,300 ppm. Case studies were not conclusive that methylene
chloride was the causative agent of alteration of liver enzymes or hepatitis (OSHA). As a result
of the review of studies in animals and humans and case reports, OSHA concluded that human
heptotoxicity is not likely (OSHA, 1997).
Animal studies have shown the fetus is sensitive to the methylene chloride metabolite,
carbon monoxide producing central nervous system damage or reduced fetal growth. Limited
data is available regarding teratogenicity effects in humans (OSHA, 1997). Carbon monoxide, a
metabolite of methylene chloride, which reduces the amount of oxygen available to tissues, has
been shown to have resulted in fetal or infant death (OSHA, 1997). OSHA concluded that it is
aware of the reproductive effects of carbon monoxide and, therefore, there is still concern about
the potential for methylene chloride teratogenicity. OSHA will continue to monitor research as it
becomes available (OSHA, 1997).
Ultimately, the exposure limits established by OSHA are based on carcinogenic and
central nervous system effects (OSHA, 1997).

4.2. Occupational Exposure Review
No studies specific to methylene chloride exposure during the manufacture of active
pharmaceutical ingredients were found with the exception of one which studied the risk for
spontaneous abortion for females working in the pharmaceutical industry (Taskinen, 1986). The
study supported there is increased risk of harmful effects on the pregnancy of female
pharmaceutical workers using methylene chloride (Taskinen, 1986). Other factors (e.g., use of
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four or more other solvents and heavy lifting) also increased the risk for spontaneous abortion
(Taskinen, 1986). The study did not document exposure levels or other potential risk factors.
This study was included in the human studies reviewed by OSHA for reproductive toxicity.
OSHA concluded more research is necessary to evaluate the effects of methylene chloride
exposure on potential pregnancy outcome (OSHA, 1997).
A study of the effects of occupational exposure to methylene chloride and the subsequent
production of COHb through metabolism in cellulose diacetate and triacetate fiber production
workers in Rock Hill, South Carolina suggested no excess mortality was observed for ischemic
heart disease (OSHA, 1997). NIOSH suggested that the study did not follow appropriate
analytical techniques and additional studies are needed to evaluate the cardiac disease risks
associated with methylene chloride exposure (OSHA, 1997). In an update to this study,
bilary/liver cancer mortality was considered. While observed, it was not considered significantly
significant (OSHA, 1997).
A study of cellulose diacetate and triacetate fiber production workers in Cumberland,
Maryland evaluated the relationship between exposure to methylene chloride and bilary/liver
cancer (OSHA, 1997). In this study, incidents of bilary/liver cancer were observed, but no
statistically significant elevated incidence was found (OSHA, 1997). Statistically significant
mortality was observed from prostate, uterine and cervical cancers and is considered to be
suggestive, but not conclusive evidence of the human carcinogenic effect (OSHA, 1997).
Studies including a proportional mortality study and a retrospective mortality cohort
study of film production workers exposed to methylene chloride were conducted (OSHA, 1997).
No statistical significance was noted for these workers for ischemic heart disease or liver cancer
in the proportional mortality study (OSHA, 1997). The cohort mortality study did identify
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differences when compared with an external population, but it was not significantly significant
(OSHA, 1997).
An epidemiological study of employees exposed to methylene chloride during the
manufacture of paint or varnish did identify cancers of the digestive organs, including the
pancreas and peritoneum, but these were not considered to be statistically significant (OSHA,
1997).
A case-control study for astrocytic brain cancer among workers exposed to methylene
chloride while producing or repairing electronic equipment suggests an association between
methylene chloride exposure and brain cancer (OSHA, 1997). This study specifically looked at
the potential association between brain cancer and exposure to chlorinated aliphatic
hydrocarbons including methylene chloride. Duration of employment for occupations or
industries with exposure, a cumulative exposure score and “average” intensity of exposure were
used as surrogate measures of exposure (OSHA, 1997). Exposure intensity categories were used
for calculating odds ratios. As the probability of exposure to organic solvents, particularly
methylene chloride, increased so did the risk for brain cancer (OSHA, 1997).

5. Research Design and Methods
The results of exposure sampling data were evaluated and compared to the OSHA PEL
and AL. OSHA requires exposure monitoring to be accurate at the 95% confidence interval to
within plus or minus 25% at concentrations above 25 ppm and within plus or minus 35% at
concentrations between 12.5 and 25 ppm.
For the manufacturer of active pharmaceutical ingredients, exposure to methylene
chloride occurs during the transfer of the methylene chloride from pails into the reactor. After the
liquid is contained within the reactor vessel, the process operates in a closed system during
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which there is no exposure. Exposure may also occur when fractions are then extracted from the
reactor by draining the contents from the bottom of the reactor.
Established OSHA methylene chloride sampling methods (i.e., OSHA 80 and OSHA 59)
are established for 5-minute sampling periods (OSHA, no date provided). Due to the Class I
Division 2 requirements of the room, passive badges were selected over utilizing charcoal tubes
with air sampling pumps. Exposure monitoring was conducted utilizing 3M Organic Vapor
Monitors Badge 3520 (3520 Monitor). Sampling for methylene chloride using the 3520 Monitor
is shown to meet the OSHA accuracy requirements for methylene chloride (OSHA, 1997).
The badges contain a charcoal adsorbent pad and operate on the principle of diffusion.
Temperature affects will not be significant between 50 and 104 degrees Fahrenheit (°F). The
temperature of the building is controlled to be within this range. Relative humidity levels can
affect sampler accuracy. High relative humidity during sampling may result in decreased
recovery (3M, 1997). Uptake of methylene chloride can be affected at relative humidity rates
exceeding 50% at which the capacity may be significantly reduced (3M, 1997). Relative
humidity was measured and recorded at the time exposure monitoring was initiated. All relative
humidity readings were below 50%.
Occupational exposure sampling was conducted during three client campaigns in
February and March 2014. The campaigns follow similar work procedures and each included
approximately 100 kilograms (i.e., between 80 and 100 kilograms) of methylene chloride. Each
of the campaigns followed the same process detailed in section 1.1 Process Description. The
difference between the campaigns would have included the proprietary active ingredient and
slight variations in the volume of chemicals used.
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The employee anticipated to have the greatest exposure to methylene chloride (i.e., the
employee that was responsible for transferring methylene chloride from pails into the reactor)
was selected to wear the 3520 Monitor for the initial sampling event. After the initial exposure
monitoring indicated the AL was exceeded, both employees involved with the process wore
monitoring badges in subsequent sampling events. Manufacturing events do not occur on a
regular schedule. Rather the events are sporadic, occurring with client demand. Two sampling
events occurred in February 2014 and one sampling event occurred in March 2014.
The badges were distributed at the beginning of the monitoring period. The badge is
clipped to the laboratory coat collar to take a personal breathing zone air sample and be
representative of the employee’s exposure. The badges were worn by employees for the full
duration of the manufacturing process. Upon completion of the monitoring, the plastic ring and
white film were removed from the monitor and caps secured to each portion of the monitor in
preparation for shipment to the analytical lab.
After observing work activities during the initial campaign, a 3520 Monitor was issued to
two employees performing these activities during the second and third campaigns. This allowed
for the exposure of the employee transferring the liquid as well as a support employee that would
transport closed containers. These are the only two employees within the room during these
procedures.
The samples were analyzed by ALS Environmental, a laboratory accredited by the
American Industrial Hygiene Association (AIHA) as an industrial hygiene laboratory.
As detailed in Section 1.1 Process Description, during work activities both employees
wear supplied-air, full-faced respirators, laboratory coats and chemical-compatible gloves. In
addition, localized ventilation (i.e., extraction arm) is positioned near the opening of the reactor.
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6. Results
The occupational exposure sampling was conducted in accordance with a method that
will provide an initial exposure determination in accordance with 29 CFR 1910.1052.
Conducting 8-hour methylene chloride sampling with the 3M 3520 badge meets the OSHA
accuracy requirements (3M, 1997).
An 8-hour work shift is composed of 480 minutes. Exposure during the time period not
monitored would have occurred outside the laboratory as office time and would not have had any
methylene chloride exposure. The typical work shift is 8-hours, but may vary with the time
needed for the solution to separate. Employees would wear the badges for the duration of their
work in the laboratory. The employees continued to wear the badges during breaks or office time
(i.e., the badges were not left in the laboratory). In the event the employee’s work in the
laboratory was completed for the day and they would not be returning, the badge was collected.
To calculate the methylene chloride exposure for an 8-hour time-weighted average (TWA),
equation (1) shown below was utilized.
(Concentration1 * Time1) + (Concentration2 * Time2)
TWA =

Time

The calculated analytical results and calculated 8-hour TWA are presented below in
Table II.

(1)
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Table II: Analytical Results and 8-Hour TWA
Sample
NG5160
NG5155
NW6944
NW7307
NG6937
NW7305
NW7307

Campaign
1
2
2
3
3
NA
NA

Location
Employee 1
Employee 2
Employee 1
Employee 2
Employee 1
Blank
Blank

Relative
Humidity
(%)
7.1
20.5
29.1
24.6
25.0
NA
NA

Exposure
Time
(minutes)
361
568
413
180
510
NA
NA

Analytical
Results
(ppm)
22
15
22
110
38
ND
ND

8-Hour
TWA (ppm)
16.65
17.75
18.93
41.25
40.38
ND
ND

NA = not applicable
ND = non-detect
The American Industrial Hygiene Association’s (AIHA’s) Industrial Hygiene Statistic
(IHSTAT) tool to perform statistical calculations of industrial hygiene data was utilized to
interpret these results (AIHA, 1998). The spreadsheet is presented in Appendix C.
The W-test value indicates the rejection of the normal distribution and the lognormal
distribution is not rejected.
The Logprobability Plot and Least Squares Best Fit Line indicates an excellent fit as the
data (i.e., the white circles) are near the line. The Linear Probability Plot and Least Squares Best
Fit Line does not fit as indicated by the data point not being visible on the graph.
Based on this information, the data set is lognormally distributed. Therefore, the
lognormal statistics are used to interpret the results.
The arithmetic mean is estimated to be 26.91 ppm. The Upper Confidence Limit (UCL),
indicated by the cell labeled UCL1, 95% %>OEL, indicates that the PEL is exceeded 76.33% of
the time. Based on this analysis, the exposure level is unacceptable when compared with the
established PEL.
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7. Discussion
The OSHA regulation 29 CFR 1910.1052 establishes an AL of 12.5 ppm as an 8-hour
TWA and a PEL of 25 ppm as an 8-hour TWA.
Null hypothesis 1, employee exposure to methylene chloride will be equal to or less than
the OSHA PEL, is rejected.
Null hypothesis 2, employee exposure to methylene chloride will be equal to or less than
the OSHA AL, is rejected.
A short-term exposure limit (STEL), established by OSHA to be 125 ppm for methylene
chloride as determined over a sampling period of 15 minutes, was not conducted as part of this
assessment. It is recommended that additional monitoring be conducted to determine the shortterm exposure of employees for comparison to the STEL.
As the exposure levels exceed the AL and the PEL, the continued monitoring should
occur at the frequency shown in Table 1 of the OSHA standard (OSHA, 2012) (see Table III).
This table indicates sampling should e conducted for the PEL and the STEL every three months.
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Table IIII: Initial Determination Exposure Scenarios and Their Associated Monitoring
Frequencies
Exposure scenario

Required monitoring activity

Below the action level and at or below the
STEL.

No 8-hour TWA or STEL monitoring required.

Below the action level and above the STEL

No 8-hour TWA monitoring required; monitor STEL exposures every three months.

At or above the action level, at or below the
TWA, and at or below the STEL.

Monitor 8-hour TWA exposures every six months.

At or above the action level, at or below the
TWA, and above the STEL.

Monitor 8-hour TWA exposures every six months and monitor STEL exposures every
three months.

Above the TWA and at or below the STEL

Monitor 8-hour TWA exposures every three months. In addition, without regard to the
last sentence of the note to paragraph (d)(3), the following employers must monitor
STEL exposures every three months until either the date by which they must achieve
the 8-hour TWA PEL under paragraph (n) of this section or the date by which they in
fact achieve the 8-hour TWA PEL, whichever comes first: employers engaged in
polyurethane foam manufacturing; foam fabrication; furniture refinishing; general
aviation aircraft stripping; product formulation; use of MC-based adhesives for boat
building and repair, recreational vehicle manufacture, van conversion, or upholstery;
and use of MC in construction work for restoration and preservation of buildings,
painting and paint removal, cabinet making, or floor refinishing and resurfacing.

Above the TWA and above the STEL

Monitor 8-hour TWA exposures and STEL exposures every three months.

(OSHA, 2012)

While this project been adequate to reject or not reject the hypotheses, additional
monitoring to assess short-term exposure is necessary.

8. Conclusions
Methylene chloride is a suspect human carcinogen and may result in central nervous
system effects, cardiac toxicity, hepatic toxicity, and reproductive toxicity. Due to these risks, it
is important to evaluate exposure levels. Based on the results, it has been determined that
employees are exposed to methylene chloride above the OSHA PEL and AL.
The results of the occupational exposure sampling indicate employees are exposed to
levels of methylene chloride above the PEL and the AL. The regulatory standard requires
respiratory protection and regulation of the work area when employees are exposure above the
PEL. Medical monitoring is required for employees exposed to levels above the AL or the PEL.
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Recommendations to reduce exposure include identifying a substitute solvent that is less
hazardous. Substitution is considered the ideal method for reducing employee exposure to
methylene chloride.
To control exposure through an engineering control, an evaluation of the current
localized ventilation system would be valuable in determining existing capabilities for reducing
exposure to methylene chloride vapors. If this is not possible with the current ventilation system,
other ventilation options could be explored.
An engineering control to reduce exposure during methylene chloride transfer from pails
to the reactor may be achieved by applying nitrogen pressure to the bucket to force methylene
chloride from one container to the reactor vessel from a remote location.
Reduction of exposure during transfer from the bottom of the reactor to collection pails
may be achieved by attaching a hose to the bottom of the reactor and channeling discharge into a
closed top container.
The implementation of any of these controls would necessitate additional exposure
monitoring to evaluate the effectiveness.
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Appendix A: Laboratory Results

06-Mar-2014
Janet Rullman
Nitto Denko Avecia
8560 Reading Road
Cincinnati, OH 45215

Tel: (513) 771-3667
Fax: (508) 482-7510
Re:

Work Order: 1402645

NOA

Dear Janet,
ALS Environmental received 4 samples on 27-Feb-2014 01:30 PM for the analyses presented in the
following report.
The analytical data provided relates directly to the samples received by ALS Environmental and for only
the analyses requested.
QC sample results for this data met laboratory specifications. Any exceptions are noted in the Case
Narrative, or noted with qualifiers in the report or QC batch information. Should this laboratory report
need to be reproduced, it should be reproduced in full unless written approval has been obtained from
ALS Laboratory Group. Samples will be disposed in 30 days unless storage arrangements are made.
The total number of pages in this report is 7.
If you have any questions regarding this report, please feel free to contact me.
Sincerely,

Chris Gibson
Electronically approved by: Rob Nieman

Chris Gibson
Project Manager

ADDRESS 4388 Glendale Milford Rd Cincinnati, Ohio 45242- | PHONE (513) 733-5336 | FAX (513) 733-5347
ALS GROUP USA, CORP. Part of the ALS Group An ALS Limi ted Company

ALS Environmental
Client:
Project:
Work Order:

Date: 06-Mar-14

Nitto Denko Avecia
NOA
1402645

Lab Samp ID Client Sample ID
1402645-01 NG5160
1402645-02 NG5155
1402645-03 NW6944
1402645-04 NW7305

Work Order Sample Summary
Matrix
Air
Air
Air
Air

Tag Number

Collection Date
2/27/2014
2/27/2014
2/27/2014
2/27/2014

Date Received Hold
2/27/2014 13:30
2/27/2014 13:30
2/27/2014 13:30
2/27/2014 13:30
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Date: 06-Mar-14

ALS Environmental
Client:
Project:
Work Order:

Nitto Denko Avecia
NOA
1402645

Case Narrative

The sample condition upon receipt was acceptable except where noted.
Results relate only to the items tested and are not blank corrected unless indicated.
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Date: 06-Mar-14

ALS Environmental
Client:
Project:

Nitto Denko Avecia
NOA

Work Order: 1402645

Analytical Results

Lab ID:
1402645-01A
Client Sample ID: NG5160

Collection Date: 2/27/2014
Matrix: AIR

Analyses
Method: 3M

ANALYTE(S) BY 3M OVM ANALYSIS GUIDE
Date Analyzed: 3/6/2014
µg/sample
Methylene Chloride

890

Reporting Limit
µg/sample
10

Lab ID:
1402645-02A
Client Sample ID: NG5155

Time (Min): 361

Analyst: TSA

ppm
22

Collection Date: 2/27/2014
Matrix: AIR

Analyses
Method: 3M

ANALYTE(S) BY 3M OVM ANALYSIS GUIDE
Date Analyzed: 3/6/2014
µg/sample
Methylene Chloride

970

Reporting Limit
µg/sample
10

Lab ID:
1402645-03A
Client Sample ID: NW6944

Time (Min): 568

Analyst: TSA

ppm
15

Collection Date: 2/27/2014
Matrix: AIR

Analyses
Method: 3M

ANALYTE(S) BY 3M OVM ANALYSIS GUIDE
Date Analyzed: 3/6/2014
µg/sample
Methylene Chloride

1,000

Reporting Limit
µg/sample
10

Lab ID:
1402645-04A
Client Sample ID: NW7305

Time (Min): 413

Analyst: TSA

ppm
22

Collection Date: 2/27/2014
Matrix: AIR

Analyses
Method: 3M

ANALYTE(S) BY 3M OVM ANALYSIS GUIDE
Date Analyzed: 3/6/2014
µg/sample
Methylene Chloride

ND

Reporting Limit
µg/sample
10

Time (Min): 0

Analyst: TSA

ppm
NA

Note:
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ALS Environmental
Client:
Work Order:
Project:
Batch ID: 21206
MBLK

Date: 06-Mar-14

Nitto Denko Avecia
1402645
NOA

QC BATCH REPORT

Instrument ID: GC4

Sample ID: MBLK-21206-21206

Client ID:

Run ID: GC4_140306A

Analyte

Result

PQL

ND

10

Methylene Chloride
LCS

Method: 3M

SPK Val

Sample ID: LCS-21206-21206

Client ID:

Run ID: GC4_140306A

Analyte

Result

PQL

SPK Val

Methylene Chloride

144.4

10

132.5

LCSD

Sample ID: LCSD-21206-21206

Client ID:

Run ID: GC4_140306A

Analyte

Result

PQL

SPK Val

Methylene Chloride

161.9

10

132.5

The following samples were analyzed in this batch:

Note:

1402645-01A
1402645-04A

Units: µg/sample
SeqNo: 775248
SPK Ref
Value

%REC

Analysis Date: 3/6/2014
Prep Date:
DF: 1

Control
Limit

Units: µg/sample
SeqNo: 775249
SPK Ref
Value
0

0

%REC

Control
Limit

109

70-130

Qual

RPD Ref
Value

%RPD

RPD
Limit

Qual

0
Analysis Date: 3/6/2014
DF: 1

Prep Date:

%REC

Control
Limit

122

70-130

1402645-02A

%RPD

RPD
Limit

Analysis Date: 3/6/2014
Prep Date:
DF: 1

Units: µg/sample
SeqNo: 775254
SPK Ref
Value

RPD Ref
Value

RPD Ref
Value
144.4

%RPD
11.4

RPD
Limit

Qual

20

1402645-03A

See Qualifiers Page for a list of Qualifiers and their explanation.
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Date: 06-Mar-14

ALS Environmental
Client:
Project:
WorkOrder:

Nitto Denko Avecia
NOA
1402645

QUALIFIERS,
ACRONYMS, UNITS

Qualifier
*
a
B
E
H
J
n
ND
O
P
R
S
U

Description
Value exceeds Regulatory Limit
Not accredited
Analyte detected in the associated Method Blank above the Reporting Limit
Value above quantitation range
Analyzed outside of Holding Time
Analyte detected below quantitation limit
Not offered for accreditation
Not Detected at the Reporting Limit
Sample amount is > 4 times amount spiked
Dual Column results percent difference > 40%
RPD above laboratory control limit
Spike Recovery outside laboratory control limits
Analyzed but not detected above the MDL

Acronym
DUP
E
LCS
LCSD
MBLK
MDL
MQL
MS
MSD
PDS
PQL
SDL
SW

Description
Method Duplicate
EPA Method
Laboratory Control Sample
Laboratory Control Sample Duplicate
Method Blank
Method Detection Limit
Method Quantitation Limit
Matrix Spike
Matrix Spike Duplicate
Post Digestion Spike
Practical Quantitaion Limit
Sample Detection Limit
SW-846 Method

Units Reported
µg/sample

Description
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ALS Environmental
Sample Receipt Checklist
Client Name:

NITTODENKOAVECIA-CINCINN

Date/Time Received:

27-Feb-14 13:30

Work Order:

1402645

Received by:

RDN

Checklist completed by:

Shannon Darling

27-Feb-14

eSignature

Matrices:
Carrier name:

Reviewed by:

Date

Rob Nieman
eSignature

04-Mar-14
Date

Client

Shipping container/cooler in good condition?

Yes

No

Not Present

Custody seals intact on shipping container/cooler?

Yes

No

Not Present

Custody seals intact on sample bottles?

Yes

No

Not Present

Chain of custody present?

Yes

No

Chain of custody signed when relinquished and received?

Yes

No

Chain of custody agrees with sample labels?

Yes

No

Samples in proper container/bottle?

Yes

No

Sample containers intact?

Yes

No

Sufficient sample volume for indicated test?

Yes

No

All samples received within holding time?

Yes

No

Container/Temp Blank temperature in compliance?

Yes

No

Water - VOA vials have zero headspace?

Yes

No

No VOA vials submitted

Water - pH acceptable upon receipt?

Yes

No

N/A

pH adjusted?
pH adjusted by:

Yes

No

N/A

Temperature(s)/Thermometer(s):
Cooler(s)/Kit(s):

Login Notes:

Client Contacted:

Date Contacted:

Contacted By:

Regarding:

Person Contacted:

Comments:

CorrectiveAction:
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14-Mar-2014
Janet Rullman
Nitto Denko Avecia
8560 Reading Road
Cincinnati, OH 45215

Tel: (513) 301-8058
Fax: (508) 482-7510
Re:

DCM/MC; NDA

Work Order: 1403271

Dear Janet,
ALS Environmental received 3 samples on 11-Mar-2014 12:32 PM for the analyses presented in the
following report.
The analytical data provided relates directly to the samples received by ALS Environmental and for only
the analyses requested.
QC sample results for this data met laboratory specifications. Any exceptions are noted in the Case
Narrative, or noted with qualifiers in the report or QC batch information. Should this laboratory report
need to be reproduced, it should be reproduced in full unless written approval has been obtained from
ALS Laboratory Group. Samples will be disposed in 30 days unless storage arrangements are made.
The total number of pages in this report is 6.
If you have any questions regarding this report, please feel free to contact me.
Sincerely,

Chris Gibson
Electronically approved by: Chris Gibson

Chris Gibson
Project Manager

ADDRESS 4388 Glendale Milford Rd Cincinnati, Ohio 45242- | PHONE (513) 733-5336 | FAX (513) 733-5347
ALS GROUP USA, CORP. Part of the ALS Group An ALS Limited Company

ALS Environmental
Client:
Project:
Work Order:
Lab Samp ID
1403271-01
1403271-02
1403271-03

Date: 14-Mar-14

Nitto Denko Avecia
DCM/MC; NDA
1403271
Client Sample ID
NW 6937
NW 7306
NW 7307

Work Order Sample Summary
Matrix
Air
Air
Air

Tag Number

Collection Date
3/4/2014
3/4/2014
3/4/2014

Date Received Hold
3/11/2014 12:32
3/11/2014 12:32
3/11/2014 12:32
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Date: 14-Mar-14

ALS Environmental
Client:
Project:

Nitto Denko Avecia
DCM/MC; NDA

Lab ID:

1403271-01A

Work Order: 1403271

Analytical Results
Collection Date: 3/4/2014
Matrix: AIR

Client Sample ID: NW 6937
Analyses
Method: 3M

ANALYTE(S) BY 3M OVM ANALYSIS GUIDE
Date Analyzed: 3/12/2014
µg/sample
Methylene Chloride

Lab ID:

2,200

Reporting Limit
µg/sample
10

1403271-02A

Time (Min): 510

Analyst: TSA

ppm
38

Collection Date: 3/4/2014
Matrix: AIR

Client Sample ID: NW 7306
Analyses
Method: 3M

ANALYTE(S) BY 3M OVM ANALYSIS GUIDE
Date Analyzed: 3/12/2014
µg/sample
Methylene Chloride

Lab ID:

2,300

Reporting Limit
µg/sample
10

1403271-03A

Time (Min): 180

Analyst: TSA

ppm
110

Collection Date: 3/4/2014
Matrix: AIR

Client Sample ID: NW 7307
Analyses
Method: 3M

ANALYTE(S) BY 3M OVM ANALYSIS GUIDE
Date Analyzed: 3/12/2014
µg/sample
Methylene Chloride

ND

Reporting Limit
µg/sample
10

Time (Min): 0

Analyst: TSA

ppm
NA

Note:
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Date: 14-Mar-14

ALS Environmental
Client:
Work Order:
Project:
Batch ID: 21358
MBLK

Nitto Denko Avecia
1403271
DCM/MC; NDA

QC BATCH REPORT

Instrument ID GC4

Sample ID MBLK-21358-21358

Client ID:

Run ID: GC4_140312A

Analyte

Result

PQL

ND

10

Methylene Chloride
LCS

Run ID: GC4_140312A

Analyte
Methylene Chloride

Result

PQL

SPK Val

134.6

10

132.5

Sample ID LCSD-21358-21358

Client ID:

Run ID: GC4_140312A

Analyte
Methylene Chloride

Result

PQL

SPK Val

130.8

10

132.5

The following samples were analyzed in this batch:

Note:

SPK Val

Sample ID LCS-21358-21358

Client ID:

LCSD

Method: 3M

1403271-01A

Units: µg/sample
SeqNo: 780720
SPK Ref
Value

%REC

Analysis Date: 3/12/2014
Prep Date: 3/12/2014
DF: 1

Control
Limit

Units: µg/sample
SeqNo: 780721
SPK Ref
Value

%REC
0

102

0

Control
Limit

RPD Ref
Value

70-130

Qual

%RPD

RPD
Limit

Qual

0
Analysis Date: 3/12/2014
Prep Date: 3/12/2014
DF: 1

%REC

Control
Limit

98.7

70-130

1403271-02A

%RPD

RPD
Limit

Analysis Date: 3/12/2014
Prep Date: 3/12/2014
DF: 1

Units: µg/sample
SeqNo: 780725
SPK Ref
Value

RPD Ref
Value

RPD Ref
Value
134.6

%RPD
2.86

RPD
Limit

Qual

20

1403271-03A

See Qualifiers Page for a list of Qualifiers and their explanation.
QC Page: 1 of 1

Date: 14-Mar-14

ALS Environmental
Client:
Project:
WorkOrder:

Nitto Denko Avecia
DCM/MC; NDA
1403271

QUALIFIERS,
ACRONYMS, UNITS

Qualifier
*
a
B
E
H
J
n
ND
O
P
R
S
U

Description
Value exceeds Regulatory Limit
Not accredited
Analyte detected in the associated Method Blank above the Reporting Limit
Value above quantitation range
Analyzed outside of Holding Time
Analyte detected below quantitation limit
Not offered for accreditation
Not Detected at the Reporting Limit
Sample amount is > 4 times amount spiked
Dual Column results percent difference > 40%
RPD above laboratory control limit
Spike Recovery outside laboratory control limits
Analyzed but not detected above the MDL

Acronym
DUP
E
LCS
LCSD
MBLK
MDL
MQL
MS
MSD
PDS
PQL
SDL
SW

Description
Method Duplicate
EPA Method
Laboratory Control Sample
Laboratory Control Sample Duplicate
Method Blank
Method Detection Limit
Method Quantitation Limit
Matrix Spike
Matrix Spike Duplicate
Post Digestion Spike
Practical Quantitaion Limit
Sample Detection Limit
SW-846 Method

Units Reported
µg/sample

Description
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ALS Environmental
Sample Receipt Checklist
Client Name:

NITTODENKOAVECIA-CINCINNA

Date/Time Received:

11-Mar-14 12:32

Work Order:

1403271

Received by:

JNW

Checklist completed by

Rob Nieman

11-Mar-14

eSignature

Matrices:
Carrier name:

Reviewed by:

Date

eSignature

Date

Client

Shipping container/cooler in good condition?

Yes

No

Not Present

Custody seals intact on shipping container/cooler?

Yes

No

Not Present

Custody seals intact on sample bottles?

Yes

No

Not Present

Chain of custody present?

Yes

No

Chain of custody signed when relinquished and received?

Yes

No

Chain of custody agrees with sample labels?

Yes

No

Samples in proper container/bottle?

Yes

No

Sample containers intact?

Yes

No

Sufficient sample volume for indicated test?

Yes

No

All samples received within holding time?

Yes

No

Container/Temp Blank temperature in compliance?

Yes

No

Water - VOA vials have zero headspace?

Yes

No

No VOA vials submitted

Water - pH acceptable upon receipt?

Yes

No

N/A

pH adjusted?
pH adjusted by:

Yes

No

N/A

Temperature(s)/Thermometer(s):
Cooler(s)/Kit(s):

Login Notes:

Client Contacted:

Date Contacted:

Contacted By:

Regarding:

Person Contacted:

Comments:

CorrectiveAction:

SRC Page 1 of 1

Appendix B: Calculations

Using equation (1) and the laboratory analytical results, the 8-hour TWA for each sample
was calculated.
(22 ppm* 361 minutes) + (0 ppm * 119 minutes)
TWA(Campaign 1 – Employee 1) =

480 minutes

= 16.55 ppm

(15 ppm* 568 minutes)
TWA(Campaign 2 – Employee 2) =

480 minutes

= 17.75 ppm

(22 ppm* 413 minutes) + (0 ppm * 67 minutes)
TWA(Campaign 2 – Employee 1) =

480 minutes

= 18.93 ppm

(110 ppm* 180 minutes) + (0 ppm * 300 minutes)
TWA(Campaign 3 – Employee 2) =

= 41.25 ppm
480 minutes

(38 ppm* 510 minutes)
TWA(Campaign 3 – Employee 1) =

= 40.38 ppm
480 minutes

Appendix C: IHSTAT

Industrial Hygiene Statistics
Concentration

OEL
25
Sample
data

Descriptive statistics

16.65
17.75
18.93
41.25
40.38

Sequential Data Plot

45

Number of samples (n)
Maximum (max)
Minimum (min)
Range
Mean
Median
Standard deviation (s)
Geometric mean
Geometric standard deviation
Percent above OEL

Sequential Data Plot

40
35
30
25

5
41.25
16.65
24.6
26.992
18.930
12.648
24.767
1.581
40.0%

20
15
10
5
0
0

1

2

3

4

5

0.045

Idealized Lognormal Distribution

Test for distribution fit
W-test of log-transformed data
Lognormal (α = 0.05) ?

0.764
Yes



0.04

W-test of data
Normal (α = 0.05) ?

0.743
No



0.035

Lognormal parametric statistics

Idealized Lognormal Distribution

LCL
OEL
est. AM
0.03

Estimated Arithmetic Mean - AM est. 26.907
LCL1,95% - Land's "Exact" 19.079
UCL1,95% - Land's "Exact" 52.435
95th Percentile 52.635
UTL95%,95% 169.899
Percent above OEL 49.2%
LCL1,95% %>OEL 22.505
UCL1,95% %>OEL 76.327

0.025

0.02

0.015

Normal parametric statistics
Mean
LCL1,95% - t statistics
UCL1,95% - t statistics
95th Percentile - Z
UTL95%,95%
Percent above OEL

26.992
14.933
39.051
47.798
80.14
56.26

0.01

95%ile
UCL

0.005

UTL

0
0

20
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